Safety and tolerability of sublingual immunotherapy in clinical trials and real life.

Safety and tolerability of sublingual immunotherapy in clinical trials and real life.

Item
http://www.wikidata.org/entity/Q38152657
A review of allergoid immunotherapy: is cat allergy a suitable target?Sublingual immunotherapy: World Allergy Organization position paper 2013 update.Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.Sublingual immunotherapy as an alternative to induce protection against acute respiratory infectionsEmerging drugs for allergic conjunctivitis.Immunotherapy in allergy and cellular tests: state of art.Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.Current developments for improving efficacy of allergy vaccines.Sublingual immunotherapy for allergic rhinitis: where are we now?Respiratory allergies in childhood: Recent advances and future challenges.Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up
P2860

Safety and tolerability of sublingual immunotherapy in clinical trials and real life.

Item
http://www.wikidata.org/entity/Q38152657
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safety and tolerability of sublingual immunotherapy in clinical trials and real life.
@en
type
label
Safety and tolerability of sublingual immunotherapy in clinical trials and real life.
@en
prefLabel
Safety and tolerability of sublingual immunotherapy in clinical trials and real life.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Safety and tolerability of sublingual immunotherapy in clinical trials and real life.
@en
P2093
P304
P31
P356
10.1097/ACI.0000000000000007
P433
P478
P50
P577
P698
P921